Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders edited by Elisabeth J. Van Bockstaele.

The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain.  In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Van Bockstaele, Elisabeth J. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer New York : Imprint: Springer, 2013.
Edition:1st ed. 2013.
Series:Springer eBook Collection.
Subjects:
Neurosciences.
Neurology .
Psychiatry.
Neurochemistry.
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Endocannabinoids and monoamines: modulating the modulators
  • Endocannabinoid-mediated synaptic plasticity
  • Current cannabinoid receptor nomenclature and pharmacological principles
  • Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction
  • Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders
  • Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers
  • Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion
  • Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function
  • Endocannabinoids, Monoamines and Stress
  • Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders
  • Endocannabinoid Signaling and the Regulation of the Serotonin System
  • Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors
  • Involvement of serotonergic system in cannabinoid analgesia
  • Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis.

Similar Items